- Home
- JHI vs CATX Comparison
JHI vs CATX Comparison
Compare JHI & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JHI | CATX |
|---|---|---|
| Founded | N/A | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 106.5M | 97.7M |
| IPO Year | 1994 | 2018 |
Fundamental Metrics
Financial Performance| Metric | JHI | CATX |
|---|---|---|
| Price | $12.14 | $0.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 16 |
| Target Price | N/A | ★ $9.93 |
| AVG Volume (30 Days) | 34.2K | ★ 3.7M |
| Earning Date | 01-01-0001 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $46.31 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.73 | $0.78 |
| 52 Week High | $14.26 | $6.16 |
Technical Indicators
Market Signals| Indicator | JHI | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 51.73 | 23.09 |
| Support Level | $11.73 | N/A |
| Resistance Level | $13.49 | $2.40 |
| Average True Range (ATR) | 0.14 | 0.21 |
| MACD | 0.05 | -0.02 |
| Stochastic Oscillator | 65.09 | 4.07 |
Price Performance
Historical ComparisonAbout JHI John Hancock Investors Trust
John Hancock Investors Trust is a United States-based diversified, closed-end management investment company. It seeks to generate income for distribution to its shareholders. The secondary objective of the company is capital appreciation. The portfolio composition of the fund comprises corporate bonds, U.S. government agencies, preferred securities, asset-backed securities, common stocks, short-term investments, and others. The company's portfolio includes Corporate Bonds, Term Loans, U.S Government Agency, and Others.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.